milrinone has been researched along with Heart Septal Defects, Ventricular in 4 studies
Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levosimendan compared with milrinone did not reduce the occurrence rate of acute kidney injury in infants after total corrective heart surgery for atrioventricular septal defect, ventricular septal defect, or Tetralogy of Fallot." | 9.30 | The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial. ( Castellheim, A; Keski-Nisula, J; Ricksten, SE; Romlin, BS; Suominen, PK; Synnergren, M; Thorlacius, EM; Vistnes, M; Wåhlander, H, 2019) |
| "Levosimendan compared with milrinone did not reduce the occurrence rate of acute kidney injury in infants after total corrective heart surgery for atrioventricular septal defect, ventricular septal defect, or Tetralogy of Fallot." | 5.30 | The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial. ( Castellheim, A; Keski-Nisula, J; Ricksten, SE; Romlin, BS; Suominen, PK; Synnergren, M; Thorlacius, EM; Vistnes, M; Wåhlander, H, 2019) |
| "Twenty-six infants with pulmonary hypertension undergoing ventricular septum defect repair were retrospectively allocated to milrinone group (n= 13)and olprinone group(n=13)." | 3.79 | [Comparison of the effects of phosphodiesterase III inhibitors, milrinone and olprinone, in infant corrective cardiac surgery]. ( Izumi, K; Jimi, N; Mizuno, K; Sakimura, S; Sumiyoshi, R; Yoshino, J, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nag, P | 1 |
| Chowdhury, SR | 1 |
| Behera, SK | 1 |
| Das, M | 1 |
| Narayan, P | 1 |
| Thorlacius, EM | 1 |
| Suominen, PK | 1 |
| Wåhlander, H | 1 |
| Keski-Nisula, J | 1 |
| Vistnes, M | 1 |
| Ricksten, SE | 1 |
| Synnergren, M | 1 |
| Romlin, BS | 1 |
| Castellheim, A | 1 |
| Sakimura, S | 1 |
| Yoshino, J | 1 |
| Izumi, K | 1 |
| Jimi, N | 1 |
| Sumiyoshi, R | 1 |
| Mizuno, K | 1 |
| Asamoto, M | 1 |
| Kitamura, T | 1 |
| Ohno, N | 1 |
| Muroya, M | 1 |
| Mori, Y | 1 |
| Sato, K | 1 |
| Yamada, Y | 1 |
2 trials available for milrinone and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
Levosimendan or Milrinone for Ventricular Septal Defect Repair With Pulmonary Arterial Hypertension.
Topics: Cardiotonic Agents; Child; Heart Septal Defects, Ventricular; Heart Ventricles; Humans; Hydrazones; | 2023 |
The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Creati | 2019 |
2 other studies available for milrinone and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
[Comparison of the effects of phosphodiesterase III inhibitors, milrinone and olprinone, in infant corrective cardiac surgery].
Topics: Cardiac Surgical Procedures; Female; Heart Septal Defects, Ventricular; Hemodynamics; Humans; Hypert | 2013 |
[Anesthetic management for emergency laparotomy in an adult patient with Eisenmenger syndrome: a case report].
Topics: Anesthesia, General; Cardiotonic Agents; Dobutamine; Eisenmenger Complex; Emergencies; Female; Heart | 2009 |